DesmopressinHormone TherapySafety Rating 9/10
Primary research areaDiabetes insipidus
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Research dose range0.1-0.4 mg oral; 10-40 mcg intranasal
AdministrationOral, intranasal, IV, or SC
Safety9/10 · FDA-approved (DDAVP)
NCAA D1Banned
Price Comparison
Compare vendors
No vendor pricing available for this peptide yet.
Overview
About Desmopressin
Mechanism of action
Selective V2 receptor agonist; antidiuretic without vasopressor effect
Safety profile
Hyponatremia, headache, fluid retention · Decades of use; hyponatremia risk manageable with monitoring; very well-characterized
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Desmopressin below your target.
Related pages